$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
FDA批准阿维鲁单抗(Avelumab)用于转移性默克尔细胞癌、晚期或转移性尿路上皮癌以及与阿西替尼联合用于晚期肾细胞癌的治疗
2025-10-19 11:44:20
Check Details
阿维鲁单抗(Avelumab)用法用量:推荐剂量,剂量调整、不良反应剂量调整
2025-10-19 11:44:20
Check Details
阿维鲁单抗(Avelumab)的不良反应和副作用
2025-10-19 11:44:20
Check Details
阿维鲁单抗(Avelumab)详细说明书
2025-10-19 11:44:20
Check Details
阿维鲁单抗(Avelumab)中文说明书:适应症、用法用量、不良反应、注意事项
2025-10-19 11:44:20
Check Details
达拉非尼联合曲美替尼对胶质瘤亚型有良好疗效
2025-10-19 11:44:20
Check Details
靶向药物艾伏尼布治疗胶质瘤疗效强劲
2025-10-19 11:44:20
Check Details
达拉非尼联合曲美替尼治疗BRAF V600E突变型胶质瘤具有持久的临床受益
2025-10-19 11:44:20
Check Details
berubicin获批加速通道指定!多形性胶质母细胞瘤迎来新疗法
2025-10-19 11:44:20
Check Details
FDA授予LP-184治疗多形性胶质母细胞瘤和恶性胶质瘤的孤儿药称号
2025-10-19 11:44:20
Check Details
胶质瘤的药物治疗——化疗研究进展
2025-10-19 11:44:20
Check Details
卡莫司汀晶片植入物在沈阳怎么购买?应该怎么使用?
2025-10-19 11:44:20
Check Details
1
2
...
15
16
17
18
19
20
21
...
4151
4152
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
A Revolutionary Targeted Therapy for Hematological Malignancies
2
A New Option for Advanced Renal Cell Carcinoma Treatment
3
Trametinib (Mekinist): Precision MEK1/2 Inhibition Transforming Cancer Care Short Description:
4
Pirtobrutinib: A Novel BTK Inhibitor Offering Hope for Hematologic Cancer Patients Short Description:
5
Sacituzumab Govitecan: Trop-2 Targeted ADC Clinical Medication Guide
6
Fulvestrant (Faslodex) Breast Cancer Guide: Indications, Dosage and Safety Specifications
7
Adagrasib (Krazati): Full Guide to KRAS G12C Inhibitor for Cancer Treatment
8
Comprehensive Analysis of the Third-Generation EGFR-TKI
9
ATOMIC Study: Atezolizumab Plus Chemo Improves DFS in dMMR Stage III Colon Cancer
10
Oncology Immunotherapy vs Anti-Inflammatory Biologic: Dostarlimab vs Secukinumab - A Mechanism-Centered Comparison
11
Third-Generation TKI Redefining Treatment for ALK+ & ROS1+ NSCLC
12
Brigatinib Medication Case Study: Three-Year Treatment Record and Experience Sharing of ALK-Positive Lung Cancer Patient